The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
Children's Health Insurance: 1997 Budget Reconciliation Provisions A side by side of children's health insurance budget reconciliation provisions comparing House and Senate bills as of 07/09/97.
In Their Own Words: Family Profiles As the U.S. Congress and state legislatures explore policies to cover the uninsured, the Commission has profiled four families with uninsured members, including their family budgets, to better understand how specific policy ideas will practically affect typical uninsured Americans.
A new policy brief discusses issues involving over $11 billion of S-CHIP funds that states have not spent. It has been proposed that states could apply to use the funds for unemployed workers in these tough economic times.
This fact sheet, last updated in March 2001, discusses health insurance status of low-income children and reviews current programs to provide coverage to this population.
The Center for Medicare and Medicaid Services issued an August 17, 2007, directive that would restrict states’ flexibility to continue to apply income disregards when determining eligibility for Medicaid and SCHIP coverage for expansions to children above 250 percent of the federal poverty level.
This report reviews how states have responded to the $500 million federal fund that was created by the federal welfare reform legislation in 1996 to help states maintain Medicaid coverage for individuals affected by welfare reform.
A new KFF issue brief lays out key factors for the successful rollout of COVID-19 vaccinations for younger children, ages 5 to 11. This week, the Food and Drug Administration’s (FDA) advisory committee will meet to vote on a request to authorize the Pfizer vaccine for younger children.
Increasing availability of high-quality comprehensive data disaggregated by race/ethnicity is a prerequisite for efforts to advance health equity, not only related to COVID-19 but in health and health care more broadly.
Analysis of characteristics of children under 12 in the U.S. to help inform COVID-19 vaccination efforts when they become eligible.
In his latest Axios column, Drew Altman shows that parents feel that children have fared better during COVID attending school in-person than virtually in terms of academic performance and their mental health and wellbeing.
© 2026 KFF